Vaccine Cell Lines – Derived From Cancer Cells

Armed with Knowledge

Henrietta Lacks was an African-American woman whose cancer cells are the source of the HeLa cell line, the first immortalized cell line and one of the most important cell lines in medical research. Wikipedia

What are the most common cell lines used in cell biology? – Quora

HeLa and HEK cells (answer)
https://www.quora.com/What-are-the-most-common-cell-lines-used-in-cell-biology

Dec 20, 2014 – But they are smaller than cos7 as well as hela cells. In addition to this my colleagues also use Human Embryonic Kidney 293 cells, also often referred as HEK 293 or less precisely as HEK cells. … HEK293 cells are used to produce exogenous proteins or viruses for pharmaceutical and biomedical research purpose.

Click this master link:

https://www.sciencedirect.com/topics/medicine-and-dentistry/protein-based-vaccine and truly read what is in the vaccine process. Not only are both hela and hek cells immortal cell lines,  derived from “cancer” cells in the womb of Henrietta Lacks (HeLa) for producing vaccines. But take Hep B vaccine, for example:   Generally all infants receive this vaccine except those who have become aware, due to the work of all the people in the anti-vaccine movement over the years. The Hep B vaccine that we give to most of our children  is derived using liver cells of persons chronically infected with hepatitis B virus (HPV).

Comment VLA:  Can we then assume (perhaps even state) that virtually all the vaccine mandated to our infants and teens are derived from HEX and HeLa cells which are derived from the cancer cells of Henrietta Lacks. And moreso, that each specific vaccine, such as Hepatitis B, adds a substance to the vaccine that is derived from liver cells  taken from chronically ill patients with the disease.

https://www.sciencedirect.com/topics/medicine-and-dentistry/protein-based-vaccine

Virus   (Excerpted from above link)

The first protein-based vaccines relied on natural sources of antigens. In this regard, the hepatitis B vaccine is unique in using a human source (plasma) for the vaccine antigen. Liver cells of persons chronically infected with hepatitis B virus (HBV) shed excess viral surface protein, ie, hepatitis B surface antigen (HBsAg). HBsAg was identified as a 22-nm lipoprotein particle antigen with protective epitopes. To develop a vaccine, plasma was harvested from long-term chronic hepatitis B carriers, HBsAg purified, and the final preparation subjected to one to three inactivation techniques (depending on the manufacturer) to kill HBV and any other adventitious human agents possibly present in the starting plasma.⁶⁹ This vaccine is well tolerated and highly efficacious.

The post Vaccine cell lines – Derived from CANCER CELLS appeared first on Vaccine Liberation Army.